Recommended

Subscribers

Sign in now to see personalised content appear here.

You can also see your reading history and subscription details on your subscriber page.

Why subscribe?
Find out more.

Sign up for your FREE email newsletter  +

New

Stem cell therapy will redefine regenerative medicine, says F&S

Globally, this market is expected to be worth US$40bn by 2020 and $180bn by 2030

North America

Six major projects to bring innovative pathology tests to patients for better treatment

Will receive £16m to develop new tests in a range of disease areas

Europe | R and D

Mix and match: milling options for inhalation products

To ensure proper delivery, inhalation products require APIs and carriers to be sized precisely and mixed carefully. Hosokawa Micron reviews the mixing and size reduction technologies available

Manufacturing and Equipment

Bayer to link up with Sprint Bioscience on tumour metabolism programme

Sprint will receive an upfront payment from Bayer and is eligible to receive up to €190m in milestones

Europe | R and D | Therapeutic Sector

Regulators rethink how best to oversee quality issues

Patient safety demands strict quality controls for drug manufacturers, but increasing drug shortages have led to new initiatives by the regulatory authorities that aim to streamline the oversight of new drugs, production processes and facility inspections

Packaging | Europe | North America | Regulatory | Asia

The inside view on quality issues

Non-destructive methods of product inspection can be valuable tools for investigating quality issues. Rene P Friedrichs and David M Wright, Reading Scientific Services, offer an inside view on pharmaceuticals and drug delivery devices using X-ray microtomography

Packaging | Imaging Analysis | Measurement and Analysis

Gerresheimer to purchase US plastic vials manufacturer Centor for US$725m

Screw-Loc and 1-Clic are two leading producrts in US plastic vials market

Packaging | Europe | North America | Finance

Consistency – the key to quality and compliance

Sharon Johnson, Senior VP, Quality, Product Development & Regulatory Affairs at Catalent, looks at how the newly created US FDA Office of Pharmaceutical Quality aims to prevent quality issues – and therefore drug shortages – arising by establishing a uniform global programme for drug quality

North America | Regulatory

Catalent and AAPS name competition winners

Four scientists win awards in Global Academic Competition for Life Science Leaders of Tomorrow

North America | Drug Delivery

Suiting a strategy to fit biotech behaviours

CROs and CMOs should consider different strategies when courting big biotech versus emerging or niche biopharma companies, says Nigel Walker, Managing Director, That’s Nice

R and D